Literature DB >> 10983973

Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding.

P Pissios1, I Tzameli, P Kushner, D D Moore.   

Abstract

We have developed a novel assembly assay to examine structural changes in the ligand binding domain (LBD) of the thyroid hormone receptor (TR). Fragments including the first helix of the TR LBD interact only weakly with the remainder of the LBD in the absence of hormone, but this interaction is strongly enhanced by the addition of either hormone or the corepressor NCoR. Since neither the ligand nor the corepressor shows direct interaction with this helix, we propose that both exert their effects by stabilizing the overall structure of the LBD. Current models of activation of nuclear hormone receptors focus on a ligand-induced allosteric shift in the position of the C-terminal helix 12 that generates the coactivator binding site. Our results suggest that ligand binding also has more global effects that dynamically alter the structure of the receptor LBD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10983973     DOI: 10.1016/s1097-2765(00)00026-5

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  26 in total

1.  Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor.

Authors:  Sabine Borngraeber; Mary-Jane Budny; Grazia Chiellini; Suzana T Cunha-Lima; Marie Togashi; Paul Webb; John D Baxter; Thomas S Scanlan; Robert J Fletterick
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-12       Impact factor: 11.205

2.  Alternative mRNA splicing of SMRT creates functional diversity by generating corepressor isoforms with different affinities for different nuclear receptors.

Authors:  Michael L Goodson; Brian A Jonas; Martin L Privalsky
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

3.  Dynamics of nuclear receptor Helix-12 switch of transcription activation by modeling time-resolved fluorescence anisotropy decays.

Authors:  Mariana R B Batista; Leandro Martínez
Journal:  Biophys J       Date:  2013-10-01       Impact factor: 4.033

4.  Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor delta-mediated transactivation.

Authors:  Anne-M Krogsdam; Curt A F Nielsen; Søren Neve; Dorte Holst; Torben Helledie; Bo Thomsen; Christian Bendixen; Susanne Mandrup; Karsten Kristiansen
Journal:  Biochem J       Date:  2002-04-01       Impact factor: 3.857

5.  Peptidoglycan Modifications Tune the Stability and Function of the Innate Immune Receptor Nod2.

Authors:  James E Melnyk; Vishnu Mohanan; Amy K Schaefer; Ching-Wen Hou; Catherine Leimkuhler Grimes
Journal:  J Am Chem Soc       Date:  2015-06-02       Impact factor: 15.419

6.  Androgen deprivation causes truncation of the C-terminal region of androgen receptor in human prostate cancer LNCaP cells.

Authors:  Naoki Harada; Kaoru Inoue; Ryoichi Yamaji; Yoshihisa Nakano; Hiroshi Inui
Journal:  Cancer Sci       Date:  2012-04-11       Impact factor: 6.716

7.  Carboxymefloquine, the major metabolite of the antimalarial drug mefloquine, induces drug-metabolizing enzyme and transporter expression by activation of pregnane X receptor.

Authors:  Rita Piedade; Stefanie Traub; Andreas Bitter; Andreas K Nüssler; José P Gil; Matthias Schwab; Oliver Burk
Journal:  Antimicrob Agents Chemother       Date:  2014-10-13       Impact factor: 5.191

8.  Ligand control of interaction in vivo between ecdysteroid receptor and ultraspiracle ligand-binding domain.

Authors:  Thomas Bergman; Vincent C Henrich; Uwe Schlattner; Markus Lezzi
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

9.  Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1.

Authors:  Marion Desclozeaux; Irina N Krylova; Florence Horn; Robert J Fletterick; Holly A Ingraham
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

10.  Unique functional properties of a member of the Fushi Tarazu-Factor 1 family from Schistosoma mansoni.

Authors:  Benjamin Bertin; Souphatta Sasorith; Stéphanie Caby; Frédérik Oger; Jocelyne Cornette; Jean-Marie Wurtz; Raymond J Pierce
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.